These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26697714)

  • 1. [Regulatory aspects of the development, licensing, and availability of immunological veterinary medicinal products].
    JungbMck C; Werner E; Von Messling V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):473-7. PubMed ID: 26697714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
    Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
    Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marketing authorization of veterinary medicinal products in Poland.
    Sztabińska-Koncka H; Lewicki J
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory requirements regarding cell-based medicinal products for human and veterinary use - a comparison].
    Kuhlmann-Gottke J; Duchow K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1299-305. PubMed ID: 26369765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
    Gay CG
    Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licensing of veterinary vaccines.
    Fries HH
    Acta Vet Scand Suppl; 1996; 90():83-4. PubMed ID: 8996892
    [No Abstract]   [Full Text] [Related]  

  • 10. Legislation covering the licensing of veterinary medicines in the United Kingdom.
    Morgan WJ
    Vet Rec; 1983 Oct; 113(14):310-3. PubMed ID: 6649346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccines: safety aspect assessment and regulation.
    Medjitna TD; Stadler C; Bruckner L; Griot C; Ottiger HP
    Dev Biol (Basel); 2006; 126():261-70; discussion 327. PubMed ID: 17058502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.
    Woodward KN
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):114-28. PubMed ID: 18060673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licensing procedures for immunological veterinary medicinal products in the European Union.
    Pastoret PP; Falize F
    Adv Vet Med; 1999; 41():595-607. PubMed ID: 9890046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survey of 50 years of veterinary remedy provision in the Netherlands].
    van den Bos T
    Tijdschr Diergeneeskd; 1998 Dec; 123(24):743-8. PubMed ID: 9879623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supervision of distribution and use of veterinary drugs in Schleswig-Holstein].
    Bettin U
    Dtsch Tierarztl Wochenschr; 1996 Jul; 103(7):240-3. PubMed ID: 8998935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of veterinary medicine regulatory agencies.
    Smith MV
    Rev Sci Tech; 2013 Aug; 32(2):393-408. PubMed ID: 24547645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
    Foley PL; Hill RE
    Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.